Abstract:Voltage-gated potassium channels are expressed throughout the human body and are essential for physiological functions. These include delayed rectifiers, A-type channels, outward rectifiers, and inward rectifiers. They impact electrical function in the heart (repolarization) and brain (repolarization and stabilization of the resting membrane potential). KCNQx and KCNHx encode Kv7.x and Kv11.x proteins, which form delayed rectifier potassium channels. KCNQx and KCNHx channelopathies are associated with both cardiac and neuronal pathologies. These include electrocardiographic abnormalities, cardiac arrhythmias, sudden cardiac death (SCD), epileptiform discharges, seizures, bipolar disorder, and sudden unexpected death in epilepsy (SUDEP). Due to the ubiquitous expression of KCNQx and KCNHx channels, abnormalities in their function can be particularly harmful, increasing the risk of sudden death. For example, KCNH2 variants have a dual role in both cardiac and neuronal pathologies, whereas KCNQ2 and KCNQ3 variants are associated with severe and refractory epilepsy. Recurrent and uncontrolled seizures lead to secondary abnormalities, which include autonomics, cardiac electrical function, respiratory drive, and neuronal electrical activity. Even with a wide array of anti-seizure therapies available on the market, one-third of the more than 70 million people worldwide with epilepsy have uncontrolled seizures (i.e., intractable/drug-resistant epilepsy), which negatively impact neurodevelopment and quality of life. To capture the current state of the field, this review examines KCNQx and KCNHx expression patterns and electrical function in the brain and heart. In addition, it discusses several KCNQx and KCNHx variants that have been clinically and electrophysiologically characterized. Because these channel variants are associated with multi-system pathologies, such as epileptogenesis, Kv7 channel modulators provide a potential anti-seizure therapy, particularly for people with intractable epilepsy. Ultimately an increased understanding of the role of Kv channels throughout the body will fuel the development of innovative, safe, and effective therapies for people at a high risk of sudden death (SCD and SUDEP).

[Cardiac channelopathies in the context of hereditary arrhythmia syndromes]

Ion Channel Disorders and Sudden Cardiac Death

Characterization of a Novel Mutation in the Cardiac Ryanodine Receptor That Results in Catecholaminergic Polymorphic Ventricular Tachycardia

Cardiac channelopathies in pediatrics: a genetic update

Genetic assay for inherited cardiac arrhythmia

Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death

Primary Electrical Heart Disease—Principles of Pathophysiology and Genetics

Inherited conditions of arrhythmia: translating disease mechanisms to patient management

Pathogenesis and Clinical Characteristics of Hereditary Arrhythmia Diseases

The Kir2.1-Na V 1.5 Channelosome and its role in Arrhythmias in Inheritable Cardiac Diseases

Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death

Inherited Arrhythmias Cardiomyopathies: 2007 Advancement and Workshop Consensus

Cardiac Channellopathy Induced Syncope

Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts

Sarcoplasmic Reticulum Ca2+ Dysregulation in the Pathophysiology of Inherited Arrhythmia: an Update

Cardiocerebral Channelopathy Caused by KCND3 Mutation in a Child: A Case Report.

Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies

Sudden Cardiac Death and Channelopathies: What Lies Behind the Clinical Significance of Rare Splice-Site Alterations in the Genes Involved?

Neurocardiac pathologies associated with potassium channelopathies

Precision Medicine and Cardiac Channelopathies: Human iPSCs Take the Lead

Sarcoplasmic Reticulum Ca<SUP>2+</SUP> Dysregulation in the Pathophysiology of Inherited Arrhythmia: An Update